Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. The company is headquartered in Bay Harbor Islands, Florida and currently employs 101 full-time employees. The company went IPO on 2011-11-17. The firm has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.
Follow-Up Questions
Qui est le CEO de Fortress Biotech Inc ?
Dr. Adm. Lindsay Rosenwald est le Executive Chairman of the Board de Fortress Biotech Inc, il a rejoint l'entreprise depuis 2009.
Quelle est la performance du prix de l'action FBIOP ?
Le prix actuel de FBIOP est de $9.01, il a increased de 0.08% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Fortress Biotech Inc ?
Fortress Biotech Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Fortress Biotech Inc ?
La capitalisation boursière actuelle de Fortress Biotech Inc est de $268.2M
Est-ce que Fortress Biotech Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 6 analystes ont établi des notations d'analystes pour Fortress Biotech Inc, y compris 2 achat fort, 6 achat, 1 maintien, 0 vente et 2 vente forte